Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
GenXys logo — Digital Health Tech leader with pharmacogenetics expertise p...

GenXys

Digital Health Tech leader with pharmacogenetics expertise providing excellent medication decision support applications.

Founded 2014 Canada Canada 18 employees Seed Total: $4.77M Digital Health, Enterprise Software +3

General Information

Company Name GenXys
Founded Year 2014
Location Canada Canada
Employees 18
Industries Digital Health, Enterprise Software, Health Care +2
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with GenXys. To contact GenXys, visit genxys.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does GenXys compare?

A PDF of GenXys and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting GenXys soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About GenXys

GenXys is a Digital Health Tech leader headquartered in Vancouver, Canada, specializing in pharmacogenetics. The company offers precision prescribing solutions with embedded pharmacogenetics to address inappropriate prescribing. Its clinical decision support software suite is widely utilized by major insurance providers, health systems, and pharmacies in North America. GenXys has received a $3.00M Seed Round investment on 15 March 2020 from Telus Ventures, Esplanade Ventures, and GreenShield. The company, founded in 2014, operates in the Enterprise Software, Health Care, and SaaS industries. GenXys seeks to expand its global presence through ongoing clinical studies to enhance patient safety, improve population health, and reduce healthcare costs. More information can be obtained through www.genxys.com/contact-us.

Business keywords: Precision Medicine, Pharmacogenetics, Medication Decision Support System, Digital Health, Clinical Decision Support Software, Molecular Labs, Patient Safety, Population Health, Adverse Drug Reactions, Personalized Medicine, Primary Care, Evidence-based Medicine, Medication Effectiveness, Healthcare Cost Reduction

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $3.00M 3
Telus Ventures Esplanade Ventures GreenShield
Telus Ventures, Esplanade Ventures +1
15 Mar 2020
Pre Seed Round $1.77M 2
Creative Destruction Lab Telus Ventures
Creative Destruction Lab, Telus Ventures
01 Dec 2018

GenXys Alternatives & Competitors

GenXys vs
Curbside Health
Curbside Health United States

Empower your team to practice safer, faster, more cost effective medicine with intelligent support a...

Seed
11 employees
Health Care, SaaS
GenXys vs
Glytec
Glytec United States

The only provider of insulin management software across the full continuum of care, from hospital to...

Venture round
75 employees
Health Care, Health and Wellness
GenXys vs
InsightRX
InsightRX United States

Maximize therapeutic success with precision medicine

Venture round
28 employees
Analytics, Digital Health

FAQ About GenXys

Digital Health Tech leader with pharmacogenetics expertise providing excellent medication decision support applications.
GenXys was founded in 2014.
GenXys is headquartered in Canada.
GenXys operates in Digital Health, Enterprise Software, Health Care, Health and Wellness and SaaS. Its work centres on Precision Medicine, Pharmacogenetics, Medication Decision Support System and Digital Health.
GenXys has approximately 18 employees.
GenXys has completed 2 funding rounds, raising a total of $4.77M. The latest funding stage is Seed.
Top alternatives and competitors to GenXys include Curbside Health, Glytec, InsightRX, Vigilant Health, Wellsource. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
GenXys and Curbside Health are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for GenXys, https://bouncewatch.com/company/genxys, updated 24 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes